Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Dietary Supplements

UMARY Hyaluronic Acid Recalled for Undeclared Diclofenac and Omeprazole

Agency Publication Date: December 26, 2024
Share:
Sign in to monitor this recall

Summary

MXBBB is recalling 321 bottles of UMARY Acid Hyaluronic (hyaluronic acid) 850 mg caplets because the product may be tainted with undeclared diclofenac and omeprazole. The firm initiated the recall after a distributor notification, although there is currently no laboratory data confirming the contamination in products distributed by MXBBB. If you have used this product and have health concerns, you should contact your healthcare provider or pharmacist.

Risk

Undeclared diclofenac (an anti-inflammatory drug) and omeprazole (a proton pump inhibitor) can cause serious adverse health effects or dangerous interactions with other medications. No injuries have been reported to date in connection with this recall.

What You Should Do

  1. This recall involves UMARY Acid Hyaluronic 850 mg caplets sold in 30-count bottles with UPC 7502265120323.
  2. Check your bottle for lot number 24183 and an expiration date of 07/01/28.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer MXBBB for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: UMARY ACID HYALURONIC (850 MG CAPLETS, 30-count bottle)
Variants: 850 mg, 30-count
UPC Codes:
7502265120323
Lot Numbers:
24183 (Exp 07/01/28)

Firm initiated recall after notification from distributor that product may be tainted.

Product Images

UMARY Acido Hialuronico, dietary supplement, 30 caplets

UMARY Acido Hialuronico, dietary supplement, 30 caplets

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 95777
Status: Active
Manufacturer: MXBBB
Sold By: Amazon Marketplace
Manufactured In: United States
Units Affected: 321 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท FDA Press Release ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.